ES2973607T3 - Métodos de análisis de la metilación del ADN y mutacional para la vigilancia del cáncer de vejiga - Google Patents
Métodos de análisis de la metilación del ADN y mutacional para la vigilancia del cáncer de vejigaInfo
- Publication number
- ES2973607T3 ES2973607T3 ES18729258T ES18729258T ES2973607T3 ES 2973607 T3 ES2973607 T3 ES 2973607T3 ES 18729258 T ES18729258 T ES 18729258T ES 18729258 T ES18729258 T ES 18729258T ES 2973607 T3 ES2973607 T3 ES 2973607T3
- Authority
- ES
- Spain
- Prior art keywords
- bladder cancer
- dna methylation
- analysis methods
- mutational analysis
- cancer surveillance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010005003 Bladder cancer Diseases 0.000 title 1
- 230000007067 DNA methylation Effects 0.000 title 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 title 1
- 238000004458 analytical method Methods 0.000 title 1
- 230000000869 mutational effect Effects 0.000 title 1
- 201000005112 urinary bladder cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762508274P | 2017-05-18 | 2017-05-18 | |
| PCT/US2018/033146 WO2018213550A1 (en) | 2017-05-18 | 2018-05-17 | Dna methylation and mutational analysis methods for bladder cancer surveillance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2973607T3 true ES2973607T3 (es) | 2024-06-20 |
Family
ID=62528860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18729258T Active ES2973607T3 (es) | 2017-05-18 | 2018-05-17 | Métodos de análisis de la metilación del ADN y mutacional para la vigilancia del cáncer de vejiga |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11649506B2 (es) |
| EP (1) | EP3625369B1 (es) |
| JP (1) | JP2020519296A (es) |
| CN (1) | CN110621788A (es) |
| AU (1) | AU2018269030A1 (es) |
| BR (1) | BR112019022360A2 (es) |
| CA (1) | CA3057440A1 (es) |
| ES (1) | ES2973607T3 (es) |
| IL (1) | IL269707A (es) |
| MX (1) | MX2019012260A (es) |
| SG (2) | SG10201912359XA (es) |
| WO (1) | WO2018213550A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114634982A (zh) * | 2020-12-15 | 2022-06-17 | 广州市基准医疗有限责任公司 | 一种检测多核苷酸变异的方法 |
| CN113621691A (zh) * | 2021-09-27 | 2021-11-09 | 广东省妇幼保健院 | 基于一代测序技术直接检测KLF1基因启动子区CpG甲基化的方法和试剂盒 |
| CN116013528B (zh) * | 2023-01-10 | 2023-11-24 | 中山大学孙逸仙纪念医院 | 结合fish检测的膀胱癌术后复发风险预测方法、装置及介质 |
| CN116987787A (zh) * | 2023-06-09 | 2023-11-03 | 北京泛生子基因科技有限公司 | 检测膀胱癌是否复发的装置和计算机可读存储介质 |
| CN117604101A (zh) * | 2023-09-11 | 2024-02-27 | 北京橡鑫生物科技有限公司 | 一种基因标志物组合、试剂盒及检测方法 |
| CN118006781A (zh) * | 2024-02-27 | 2024-05-10 | 广州中鑫基因医学科技有限公司 | 用于检测尿路上皮癌的标志物、引物组、高敏感性和高特异性的试剂盒及检测方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1896180B1 (en) | 2005-06-23 | 2011-11-23 | Biocartis SA | Cartridge, system and method for automated medical diagnostics |
| EP3048176B1 (en) * | 2009-04-20 | 2019-03-06 | Erasmus University Medical Center Rotterdam | Method of diagnosing bladder cancer |
| WO2010149782A1 (en) * | 2009-06-26 | 2010-12-29 | Epigenomics Ag | Methods and nucleic acids for analysis of bladder cell proliferative disorders |
| CN103417983A (zh) * | 2012-05-18 | 2013-12-04 | 北京大学 | 新的凋亡相关分子tmem106a及其用途 |
| US20150292030A1 (en) * | 2012-11-27 | 2015-10-15 | Board Of Regents, The University Of Texas System | Methods of characterizing and treating molecular subset of muscle-invasive bladder cancer |
| WO2014183093A1 (en) * | 2013-05-10 | 2014-11-13 | University Of Southern California | Dna methylation biomarkers for bladder cancer |
| EP3099822A4 (en) * | 2014-01-30 | 2017-08-30 | The Regents of the University of California | Methylation haplotyping for non-invasive diagnosis (monod) |
| GB201511152D0 (en) * | 2015-06-24 | 2015-08-05 | Ucl Business Plc | Method of diagnosing bladder cancer |
-
2018
- 2018-05-17 BR BR112019022360A patent/BR112019022360A2/pt not_active IP Right Cessation
- 2018-05-17 MX MX2019012260A patent/MX2019012260A/es unknown
- 2018-05-17 ES ES18729258T patent/ES2973607T3/es active Active
- 2018-05-17 WO PCT/US2018/033146 patent/WO2018213550A1/en unknown
- 2018-05-17 CN CN201880032698.1A patent/CN110621788A/zh active Pending
- 2018-05-17 CA CA3057440A patent/CA3057440A1/en active Pending
- 2018-05-17 AU AU2018269030A patent/AU2018269030A1/en not_active Abandoned
- 2018-05-17 JP JP2019562614A patent/JP2020519296A/ja not_active Withdrawn
- 2018-05-17 EP EP18729258.6A patent/EP3625369B1/en active Active
- 2018-05-17 SG SG10201912359XA patent/SG10201912359XA/en unknown
- 2018-05-17 SG SG11201909113V patent/SG11201909113VA/en unknown
- 2018-05-17 US US16/612,926 patent/US11649506B2/en active Active
-
2019
- 2019-09-26 IL IL26970719A patent/IL269707A/en unknown
-
2023
- 2023-04-04 US US18/130,547 patent/US20230374604A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018269030A1 (en) | 2019-10-17 |
| WO2018213550A1 (en) | 2018-11-22 |
| US11649506B2 (en) | 2023-05-16 |
| CA3057440A1 (en) | 2018-11-22 |
| EP3625369B1 (en) | 2024-02-14 |
| BR112019022360A2 (pt) | 2020-05-19 |
| MX2019012260A (es) | 2020-01-27 |
| JP2020519296A (ja) | 2020-07-02 |
| IL269707A (en) | 2019-11-28 |
| US20230374604A1 (en) | 2023-11-23 |
| EP3625369A1 (en) | 2020-03-25 |
| SG10201912359XA (en) | 2020-02-27 |
| SG11201909113VA (en) | 2019-10-30 |
| CN110621788A (zh) | 2019-12-27 |
| US20200165686A1 (en) | 2020-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2973607T3 (es) | Métodos de análisis de la metilación del ADN y mutacional para la vigilancia del cáncer de vejiga | |
| DK3294770T3 (da) | Terapeutiske og diagnostiske fremgangsmåder til cancer | |
| CL2017001901A1 (es) | Terapéuticos de glicano y métodos relacionados del mismo | |
| DK3872085T3 (da) | Stam-virussekvenser og anvendelser heraf | |
| DK3265575T3 (da) | Cd20-bindende molekyler og anvendelser deraf | |
| DK3110984T3 (da) | Martensitisk-ferritisk rustfrit stål, forarbejdet produkt og fremgangsmåder, hvor de samme anvendes | |
| SG10202001197UA (en) | Systems and methods for biological analysis | |
| DK3444191T3 (da) | Bagagebehandlingsstation og dertil hørende system | |
| DK3180907T3 (da) | Lægemiddelinformationssystem og fremgangsmåde | |
| BR112017007052A2 (pt) | métodos, aparelhos e sistemas para análise de rede. | |
| DK3171765T3 (da) | Indsamling og analyse af data til diagnostiske formål | |
| DK3202305T3 (da) | Engangsendoskop og system | |
| ES2973011T3 (es) | Síntesis del ADN | |
| DK3183260T3 (da) | Modificerede oligonukleotider og fremgangsmåder til deres syntese | |
| DK3368655T3 (da) | Forbedret proteinekspression og fremgangsmåder dertil | |
| DK3414189T3 (da) | Lagersystem og fremgangsmåde | |
| BR112016027041A2 (pt) | Combinações farmacêuticas para tratamento do câncer | |
| DK3357000T3 (da) | Systemer og fremgangsmåder til cancerdetektering | |
| SG10201913814QA (en) | Nucleic Acid Analysis Apparatus | |
| GB201419814D0 (en) | Data traffic processing and analysis | |
| BR112016020381A2 (pt) | sistemas e métodos para liberação de drogas para tratamento do câncer de bexiga com gencitabina. | |
| DK3420039T3 (da) | Printningsformuleringer og fremgangsmåder | |
| DK3389669T3 (da) | Triterpensaponinvarianter, syntesefremgangsmåder og anvendelse deraf | |
| DK3271864T3 (da) | Vævsprøveanalyseteknik | |
| DK3652314T3 (da) | Nukleinsyreekstraktionsmaterialer og -fremgangsmåder |